INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 6 filers reported holding INNATE PHARMA S A in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,265 | -17.8% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,538 | +7.9% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,425 | -23.6% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $1,865 | +86.5% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 500 | -23.1% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 650 | -50.0% | 0.00% | – |
| Q1 2021 | $5,604,000 | +140000.0% | 1,300 | +18.2% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 1,100 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q4 2019 | $7,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 4,545,454 | $29,273,000 | 2.64% |
| Rubric Capital Management LP | 1,350,000 | $8,694,000 | 0.98% |
| Maven Securities LTD | 130,000 | $836,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 44,226 | $284,000 | 0.01% |
| OLD MISSION CAPITAL LLC | 13,038 | $84,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 200,000 | $1,288,000 | 0.00% |
| FNY Investment Advisers, LLC | 1,795 | $11,000 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,353,773 | $8,705,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 74,242 | $477,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |